This inventor holds 3 USPTO granted patents. Top assignees: The General Hospital Corporation, Harvard College, University of Washington. Active years: 1998-2012.
Company Filing History:
2 out of 3,070 
1 out of 3,071 
1 out of 2,166 
Years Active: 1998-2012
Title: Innovations and Contributions of Samuel I. Miller
Introduction
Samuel I. Miller is a notable inventor based in Seattle, WA, recognized for his significant contributions to the field of bacterial infection research. With a total of 3 patents, Miller has developed innovative methods and compounds aimed at combating Gram-negative bacterial infections.
Latest Patents
Miller's latest patents include groundbreaking work on 5-substituted-2-imino-thiazolidinone compounds, which serve as inhibitors of bacterial infection. His methods focus on inhibiting Gram-negative bacterial pathogenesis and screening for compounds that inhibit type III secretion in these bacteria. Additionally, he has developed substantially pure Salmonella secreted proteins, which are crucial for diagnosing Salmonella infections and creating live attenuated vaccine strains.
Career Highlights
Throughout his career, Samuel I. Miller has worked with esteemed institutions such as The General Hospital Corporation and Harvard College. His research has significantly advanced the understanding of bacterial pathogenesis and has the potential to lead to new therapeutic strategies.
Collaborations
Miller has collaborated with notable colleagues, including Heather B. Felise and John J. Mekalanos, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Samuel I. Miller's work exemplifies the impact of innovative research on public health, particularly in the fight against bacterial infections. His patents and collaborations highlight his commitment to advancing medical science and improving health outcomes.